Motivation and avolition in schizophrenia patients: The role of self‐efficacy

Bentall, Richard P.; Simpson, Peter; Lee, David A.; Williams, Steven R.; Elves, Sue; Brabbins, Clare; Morrison, Anthony P.

doi:10.1080/17522430903505966

Cited by 27 publications

(27 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The results of the current study contribute to other recent attempts to address this gap in the literature (Bentall et al, 2010; Corrigan et al, 2006; Pratt et al, 2005; Vauth et al, 2007) and also highlight the social aspect of efficacy ( i.e. , others’ perception of our efficacy may also be an influential factor in our lives).…”

Section: Discussionsupporting

confidence: 69%

Perceptions of Efficacy, Expressed Emotion, and the Course of Schizophrenia

Breitborde¹,

López²,

Aguilera³

et al. 2013

Journal of Nervous &Amp; Mental Disease

View full text Add to dashboard Cite

Although it is clear that expressed emotion (EE) is associated with the course of schizophrenia, proposed models for this association have struggled to account for the relationship between the EE index of emotional overinvolvement (EOI) and relapse. To expand our understanding of the EOI-relapse association, we first attempted to replicate the finding that the EOI-relapse association is curvilinear among 55 Mexican-Americans with schizophrenia and their caregiving relatives. Second, we evaluated whether the caregivers’ perception of their ill relative’s efficacy may account for the EOI-relapse association. Our results comport with past findings with regard to the curvilinear nature of the EOI-relapse association among Mexican-Americans and suggest that EOI may only seem to be a risk factor of relapse because of its strong association with a true risk factor for relapse (i.e., caregivers’ perception of their ill relative’s efficacy).

show abstract

Section: Discussionsupporting

confidence: 69%

Perceptions of Efficacy, Expressed Emotion, and the Course of Schizophrenia

Breitborde¹,

López²,

Aguilera³

et al. 2013

Journal of Nervous &Amp; Mental Disease

View full text Add to dashboard Cite

show abstract

“…Lack of motivation was recognized as a possible barrier to engaging in psychological and behavioral therapies. Lack of motivation is a well-known symptom of psychosis (e.g., Bentall et al, 2010 ) which likely impacts on cognition and take-up of therapies ( Gard et al, 2009 ). This suggests that therapies that include motivational methods to engage clients maintain treatment adherence and maximize outcomes are most likely to succeed ( Gard et al, 2009 ).…”

Section: Summary and Discussionmentioning

confidence: 99%

Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study

et al. 2015

View full text Add to dashboard Cite

Symptoms of psychosis such as hallucinations and delusions can be intrusive and unwanted and often remain treatment-resistant. Due to recent progress in basic and clinical sciences, novel approaches such as sleep-based interventions are increasingly becoming offered to address the physical and mental health issues of people with severe mental illness. While the primary outcome is to improve sleep, studies have demonstrated that interventions that target symptoms of insomnia can also produce improvements in the severity of psychotic symptoms, quality of life, and functional outcomes. This study presents qualitative data on the attitudes and preferences of people with schizophrenia and schizo-affective disorders to three different types of therapies for insomnia (standard pharmacological, melatonin-based, and cognitive and/or behavior therapy). Interviews included discussions regarding the perceived advantages and limitations of different therapies, enablers to taking up the preferred option, as well as personal strategies that have helped respondents with sleep problems in the past. Results showed that, when given the choice, these individuals prefer psychological and behavioral-type therapy to other sleep interventions because of its potential to support and empower them in taking responsibility for their own recovery. Pharmacological therapies, by contrast, are viewed as useful in managing acute sleep problems, but only as a short-term solution. Overall, the findings underscore the need for patients’ active engagement when making decisions about treatment options.

show abstract

“…Well‐being was reduced significantly by a diagnosis of depression and recreational drug use, and independence in daily living was lower in people who lived alone and who had left school at a lower age. As might be anticipated, self‐efficacy, which is an indicator of self‐management (Bentall ), was lower for people having a higher alcohol intake, depression and less formal education. However, processes of care also had an effect; higher frequency of clinic appointments, and reporting that caffeine intake was monitored by clinic staff (a possible indicator of health professional attention), was associated with higher self‐efficacy.…”

Section: Discussionmentioning

confidence: 62%